135 related articles for article (PubMed ID: 23751197)
21. Brain sonography insight into the midbrain in myotonic dystrophy type 2.
Rakocevic-Stojanovic V; Peric S; Savic-Pavicevic D; Pesovic J; Mesaros S; Lavrnic D; Jovanovic Z; Pavlovic A
Muscle Nerve; 2016 May; 53(5):700-4. PubMed ID: 26425828
[TBL] [Abstract][Full Text] [Related]
22. Transcranial sonography in Huntington's disease.
Krogias C; Eyding J; Postert T
Int Rev Neurobiol; 2010; 90():237-57. PubMed ID: 20692506
[TBL] [Abstract][Full Text] [Related]
23. Echogenicity of the brainstem raphe in patients with major depression.
Becker G; Struck M; Bogdahn U; Becker T
Psychiatry Res; 1994 Jun; 55(2):75-84. PubMed ID: 10711796
[TBL] [Abstract][Full Text] [Related]
24. Transcranial sonography in patients with myotonic dystrophy type 1.
Peric S; Pavlovic A; Ralic V; Dobricic V; Basta I; Lavrnic D; Rakocevic Stojanovic V
Muscle Nerve; 2014 Aug; 50(2):278-82. PubMed ID: 24395217
[TBL] [Abstract][Full Text] [Related]
25. Alterations in transcranial sonography among Huntington's disease patients with psychiatric symptoms.
Witkowski G; Jachinska K; Stepniak I; Ziora-Jakutowicz K; Sienkiewicz-Jarosz H
J Neural Transm (Vienna); 2020 Jul; 127(7):1047-1055. PubMed ID: 32285254
[TBL] [Abstract][Full Text] [Related]
26. Relationship between rapheal echogenicity and personality as possible markers of a disposition to develop depressive and anxiety disorders.
Šilhán P; Hýža M; Hosák L; Perničková D; Vantuch J; Jelínková M; Školoudík D
Psychiatry Res Neuroimaging; 2017 May; 263():70-75. PubMed ID: 28366872
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of depressive symptoms and their association with brainstem raphe echogenicity in patients with Parkinson's disease and non-PD controls.
Toomsoo T; Randver R; Liepelt-Scarfone I; Kadastik-Eerme L; Asser T; Rubanovits I; Berg D; Taba P
Psychiatry Res Neuroimaging; 2017 Oct; 268():45-49. PubMed ID: 28865346
[TBL] [Abstract][Full Text] [Related]
28. Alteration of brainstem raphe measured by transcranial sonography in depression patients with or without Parkinson's disease.
Zhang YC; Hu H; Luo WF; Sheng YJ; Chen XF; Mao CJ; Xiong KP; Yu LF; Zhang Y; Liu CF
Neurol Sci; 2016 Jan; 37(1):45-50. PubMed ID: 26253340
[TBL] [Abstract][Full Text] [Related]
29. Serotonergic functioning as measured by the loudness dependence of auditory evoked potentials is related to a haplotype in the brain-derived neurotrophic factor (BDNF) gene.
Juckel G; Schumacher C; Giegling I; Assion HJ; Mavrogiorgou P; Pogarell O; Mulert C; Hegerl U; Norra C; Rujescu D
J Psychiatr Res; 2010 Jun; 44(8):541-6. PubMed ID: 20004415
[TBL] [Abstract][Full Text] [Related]
30. Transcranial midbrain sonography in narcoleptic subjects with and without concomitant REM sleep behaviour disorder.
Unger MM; Möller JC; Ohletz T; Stiasny-Kolster K; Oertel WH; Mayer G
J Neurol; 2009 Jun; 256(6):874-7. PubMed ID: 19252799
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics associated with different strengths of loudness dependence of auditory evoked potentials (LDAEP) in major depressive disorder.
Min JA; Lee SH; Lee SY; Chae JH; Lee CU; Park YM; Bae SM
Psychiatry Res; 2012 Dec; 200(2-3):374-81. PubMed ID: 23021319
[TBL] [Abstract][Full Text] [Related]
32. The association between suicidality and serotonergic dysfunction in depressed patients.
Kim DH; Park YM
J Affect Disord; 2013 May; 148(1):72-6. PubMed ID: 23312213
[TBL] [Abstract][Full Text] [Related]
33. Brainstem raphe lesion in patients with major depressive disorder and in patients with suicidal ideation recorded on transcranial sonography.
Budisic M; Karlovic D; Trkanjec Z; Lovrencic-Huzjan A; Vukovic V; Bosnjak J; Demarin V
Eur Arch Psychiatry Clin Neurosci; 2010 Apr; 260(3):203-8. PubMed ID: 19756820
[TBL] [Abstract][Full Text] [Related]
34. Transcranial brain parenchymal sonography in neurodegenerative and psychiatric diseases.
Mijajlovic MD; Tsivgoulis G; Sternic N
J Ultrasound Med; 2014 Dec; 33(12):2061-8. PubMed ID: 25425361
[TBL] [Abstract][Full Text] [Related]
35. The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings.
O'Neill BV; Croft RJ; Nathan PJ
Hum Psychopharmacol; 2008 Jul; 23(5):355-70. PubMed ID: 18421800
[TBL] [Abstract][Full Text] [Related]
36. A pilot study on predictors of brainstem raphe abnormality in patients with major depressive disorder.
Kostić M; Munjiza A; Pesic D; Peljto A; Novakovic I; Dobricic V; Tosevski DL; Mijajlovic M
J Affect Disord; 2017 Feb; 209():66-70. PubMed ID: 27888722
[TBL] [Abstract][Full Text] [Related]
37. Association between BDNF gene polymorphisms and serotonergic activity using loudness dependence of auditory evoked potentials in healthy subjects.
Park YM; Lee SH; Lee HJ; Kang SG; Min JA; Chae JH
PLoS One; 2013; 8(4):e60340. PubMed ID: 23593198
[TBL] [Abstract][Full Text] [Related]
38. Clinical implications of loudness dependence of auditory evoked potentials in patients with atypical depression.
Lee SH; Park YC; Yoon S; Kim JI; Hahn SW
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():7-12. PubMed ID: 24865151
[TBL] [Abstract][Full Text] [Related]
39. Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography.
Becker T; Becker G; Seufert J; Hofmann E; Lange KW; Naumann M; Lindner A; Reichmann H; Riederer P; Beckmann H; Reiners K
J Neurol Neurosurg Psychiatry; 1997 Nov; 63(5):590-6. PubMed ID: 9408098
[TBL] [Abstract][Full Text] [Related]
40. Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity.
Gudlowski Y; Ozgürdal S; Witthaus H; Gallinat J; Hauser M; Winter C; Uhl I; Heinz A; Juckel G
Schizophr Res; 2009 Apr; 109(1-3):141-7. PubMed ID: 19268544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
